Comparative proteomics analysis in different stages of urothelial bladder cancer for identification of potential biomarkers: highlighted role for antioxidant activity

Table 1 The clinicopathological characteristics of 42 urothelial bladder cancer patients

Clinicopathological characteristics	NMIBC (%) n = 25	MIBC (%) n = 17	p-value	Noncancerous (%) n = 10
Gender
Male	18 (72)	13 (76.47)	0.74	7 (70)
Female	7 (28)	4 (23.52)	0.74	3 (30)
Age (mean ± SD)	66.48 ± 9.29	66.76 ± 11.62		66.10 ± 7.03
Histological grade
Low grade	13 (52)	1 (5.88)	0.002*	-
High grade	12 (48)	16 (94.11)	0.002*	-
Tumor size (cm)
≦ 3	15 (60)	12 (70.58)	0.53	-
> 3	10 (40)	5 (29.41)	0.53	-
Pathological T stage
	Ta/T1	T2/T3/T4		-

NMIBC, Non-muscle-invasive bladder cancer; MIBC, muscle-invasive bladder cancer; * p > 0.05

ISSN: 1559-0275